| | | | 1. | (viruses associated with respiratory infection) | | | | | 2. | | | | SARS | ECHO | | 3. | RNA | | | α β γ δ | ( Coronavirus ) ( | Coronaviridae ) ( Coronavirus ) | | | 4. | | 50-200 nm | 5. | S | | N | | SARS-CoV MERS-CoV | | 6. | | 229E OC43 | SARS | 6 α 229E NL63 | β OC43 HKU1 | ( MERS-CoV ) | (SARS-CoV) | | | W H O | 2019 nCoV | 6 2019 | nCoV | | SARS-CoV MERS-CoV | β | SARS-CoV | MERS-CoV | 7. | | | | | 2002 | | | | | | | 2002 SARS | | | | | | | 8. | SARS-CoV | HKU9-1 | | | | | | | | | | 9. | | HKU1 SARS-CoV MERS-CoV 2019 -nCoV | | 10. | 56℃ 30 | 75% | | | 11. | | | | | 3-7 | | SARS 2019 — | nCoV | | SARS | | 12. | | | 13. — SARS | | SARS-CoV | (severeacuterespiratorysyndrome SARS) SARS | | SARS | 14% 40 | | | | 14. ( MERS ) | — 《 SARS 》 | 2015 2016 MERS | 2003 SARS | | | (1) | 2012 9 MERS 2015 | 5 | 1143 SARS 2003 | 32 | 8422 (2) | 《 MERS 》 | SARS | (3) | MERS SARS | SARS | 10% MERS | 40% SARS | | 15. | | | β WHO | 2019 nCoV 2020 1 10 | 2019 nCoV | 5 | | | | | | | | | 16. | | | | | 17. | | 1 | 2 | | / | / / | | ( ) | | WBC∨ 10×109/L ∧4×109/L | | 3 X | / | | 1—3 | | | 18. | | | | | | | | | | | | | | | | | | CAP | 15% -34.9% | | | | 5.8% - 65.7% | | 19. | | | | | | ( | ) | | | 20. | | | | | | | | | | 1 | | 2 | | | 3 | | | | 4 | | 21. | | | | | | | | 1 | | | 2 | 3 | 4 | | 5 | 22. | 1 | 75% | 2 20 | | | 3 100℃ | | | | 4 | | | 5 | | | 6 5‰ | 1 | | 7 | | 1-3% | | 8 | | | | | 23. | | | | | | | | | | | | | | 24. | | | | | | | | | SARS | | | 25. | | | | | | | | | | 26. | 95% | | | | | | 27. | ∨5μm | ( 1 ) | | | | 1 | 2 | | | | | SARS | A | ( ) | 28. | | ∧5μm | | | | | | | | / | | SARS | 29. | | | | ( ) | | | | | 30. | | | | | 31. | | | 1 | | 2 | | | 3 | | 4 | | 5 | | 32. 14 | | | 7 2~3 10~12 | | | | | | | | 14 | | | | | | | 33. | | | | | | | | | | | | | | | | C | D- | 34. | | RT-PCR | | | | 14 | | | C | | D- | 35. | | | | | | | 36. | | | 1 | | | | 2 | | | 3 | | | 2016 | | 2019 | | 37. | | | | | 38. | | | | | 39. | | 1 | | | | | 2 SARS/MERS | SARS MERS | | | SARS MERS | | | SARS | 40. | | | | | | | | | | 41. | | | | | | | | H1N1 H3N2 H5N1 H7N9 | | | | 42. SARS | | MERS SARS | | SARS | | 43. | | | | | | | | | | | | 44. | | | | | | | | 45. | | | | RT-PCR 2019 - nCoV | | 46. | | | | WHO | | | | | | | 47. | | | | ICU | 48. | 1 | | | 2 | 3 | | 4 | | 5 | | | 6 | | 49. | | | | | 3 | | 1 | | | 50. | | | | | 51. | | | | | | | | | | | | | | | N95 | | | | | | | | 52. | | 1 | | ( | ) | 2 | | | | 3 | | | 4 | | | 5 | | | 6 | | | 53. | | 1 | | 2 | 3 | 4 | | | | 54. | | N95 | 55. | | 1 | | | | 2 | | | 3 | | | 4 | | | | | 56. | | | | | | | | 57. | | | | | | | | | | | | | 58. | | 1m | | | | | | 59. | | | | | | | | | | | 60. WHO | | | 61. | | | | | | | | | | 62. | | | | | | | | | | | | 63. | | | | | | | | 64 . | | | | | | | IgA | N K | | | 100 | | | | | | | | | NK | | | | | | | | 65. | | | | | | | | | | 56 ℃ 30 75% | | | | | | 66. | | 1 | | 2 | 3 | | | | 4 | | | | 67. | 1 | | | 2 | | | 3 | | 4 | | 5 | | | 6 | | 7 | | 8 | | 68. | | | | | | | | | 69. | | | | | | | | | 70. | | | | | | | | | | 71. | | 1 | | | 2 | | 3 | | 4 | | 5 | | 6 | | 72. | | 1 | | | 2 | | | 3 | | | 73. | | | | WHO | | | 74. | | 1 | | | 2 | | | | | | | | 75. | | 1 | | 2 | | 3 | | | 4 | | 5 | | 76. | | 1 | | 2 | 3 | | 4 | | 77. | | | | | 78. | | SARS | MERS | SARS | SARS 2019 - nCoV | 79. | | | | | | | | | | 15 30 | | 80. | 《 | 》 | | | | | | KN95 N95 | | | 81. | | | | | | | 82. | | 75% | | | | 83. | | | | | | 84. | | | | 85. | | | | 75% | | | | | 86. | | 2 4 | | 87. | | | | | 88. | | | | N95 | 1860 9132 | | 89. | N95 95%0.3μm | | | | 90% 5μm | | | | | 90. | | | | | | | 91. | | | | | | | | | | | | 92. | | | | | | | | | 93. | | | | 《 》 | | | | | | 94. | | 1. | 2. | | 95. 《 》 | | | | | | 96. | | | 1 | | | | 2 | | | | 97. | 1 | | | | 2 | | | | 3 | | | 98. | | | | | | 99. | | 1 | | | | 2 | | | | 100. | 《 | 》 《 》 《 | 》 | | | 7 | | | | | 101. | | | | | | | | | | | |